Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of the Sensitivity and Specificity of 68Ga-HBED-CC-PSMA PET/CT in Prostate Cancer

NCT04684628 is registered in ClinicalTrials.gov with University of Saskatchewan as lead sponsor.

NCT NCT04684628
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04684628 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of the Sensitivity and Specificity of 68Ga-HBED-CC-PSMA PET/CT in Prostate Cancer
Lead sponsor
University of Saskatchewan
Phase
Phase 3
Overall status
Suspended
Start date
December 9, 2020
Completion date
December 31, 2025
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer